![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Boston Scientific’s Drug-Eluting Stent Receives FDA Approval
Boston Scientific’s Drug-Eluting Stent Receives FDA Approval
![Boston Scientific Logo](https://www.fdanews.com/ext/resources/test/Device_Images3/Boston-Scientific.gif?t=1576639660&width=430)
The FDA approved Boston Scientific’s premarket approval application for its Eluvia drug-eluting vascular stent system.
The device is developed to treat peripheral artery disease by using a drug-polymer combination to continually release paclitaxel over one year.
It is designed to stop tissue from regrowing that may become an obstruction for the stented artery.
Upcoming Events
-
21Oct